Sigyn Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE PROMISSORY DEBENTURES (Details Narrative)

CONVERTIBLE PROMISSORY DEBENTURES (Details Narrative) - USD ($)								1 Months Ended		9 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Apr. 10, 2024	Apr. 09, 2024	Dec. 31, 2023	Dec. 31, 2022	Jan. 28, 2020	Sep. 30, 2024	May 31, 2024	Sep. 30, 2024	Sep. 30, 2023
Short-Term Debt [Line Items]
Cash		$ 2,061,895						$ 2,061,895		$ 2,061,895
Aggregate numbers of warrants to purchase shares					559,839
Debt conversion amount										$ 707,730	$ 198,000
Debt conversion, shares issued										157,526
2024 Convertible Notes Four [Member]
Short-Term Debt [Line Items]
Debt conversion amount								$ 474,794	$ 232,937
Debt conversion, shares issued								118,700	38,826
2024 Convertible Notes Four [Member] \| Forecast [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 852,630
Cash	$ 771,890
Debt instrument maturity date	January and June 2025 based on $1.00 for each $0.90909 paid by the noteholders
Term of warrants	5 years
Aggregate numbers of warrants to purchase shares	213,164
Exercise price of warrants per share	$ 7.50
Proceeds from issuance of convertible debt	$ 771,891
Original issue discount	$ 80,739
2023 Convertible Notes Three [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount					$ 264,000
Cash					$ 240,000
Debt instrument maturity date					July 2024 through March 2025 based on $1.00 for each $0.90909 paid by the noteholders
Term of warrants					5 years
Aggregate numbers of warrants to purchase shares					44,002
Exercise price of warrants per share					$ 7.50
Proceeds from issuance of convertible debt					$ 240,000
Original issue discount		$ 15,400		$ 15,000	$ 24,000			$ 15,400		$ 15,400
Debt instrument conversion price per share					$ 4.00
Maturity date		Aug. 31, 2025		Mar. 31, 2025
2022 Convertible Notes Two [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount						$ 879,428
Cash						$ 700,000
Debt instrument maturity date			August 2024 and March 2025			January 2024 through December 7, 2024 based on $1.00 for each $0.90909 paid by the previous noteholder
Term of warrants						5 years
Aggregate numbers of warrants to purchase shares						240,534
Exercise price of warrants per share						$ 7.50
Proceeds from issuance of convertible debt						$ 770,000
Original issue discount		$ 56,306	$ 41,350			$ 70,000		56,306		56,306
Debt instrument conversion price per share						$ 4.00
Maturity date		Aug. 31, 2025
Convertible Promissory Note One [Member] \| Osher Capital Partners LLC [Member]
Short-Term Debt [Line Items]
Cash		$ 350,005						350,005		$ 350,005
Maturity date										Aug. 31, 2025
Convertible Promissory Note One [Member] \| Securities Purchase Agreement [Member] \| Osher Capital Partners LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount							$ 564,139
Debt instrument maturity date							August 30, 2024, based on $1.00 for each $0.90909 paid by Osher
Term of warrants							5 years
Aggregate numbers of warrants to purchase shares							102,827
Exercise price of warrants per share							$ 5.60
Proceeds from issuance of convertible debt							$ 350,005
Original issue discount		$ 56,414					$ 214,133	$ 56,414		$ 56,414
Debt instrument conversion price per share							$ 3.76